Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Jingtao Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3686-9720; OpenAlex author ID A5101877554. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. PUS7 promotes the progression of pancreatic cancer by interacting ANLN to activate MYC pathway. Last author DOI 10.1007/s11010-025-05267-2↗
  2. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex. Co-author DOI 10.1111/cas.13138↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yubo Jiang · 1 shared paper, 2025 · strength 0.37
  2. Honglong Wei · 1 shared paper, 2017 · strength 0.07
  3. Jie Li · 1 shared paper, 2017 · strength 0.07
  4. Xueying Sun · 1 shared paper, 2017 · strength 0.07
  5. Tao Li · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.